Saturday - August 29, 2026
Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy
August 28, 2026
SOPHIA ANTIPOLIS, France, Aug. 28 [Category: Medical] -- The European Society of Cardiology posted the following news release:

* * *

Aficamten trial brings positive news for patients living with non-obstructive hypertrophic cardiomyopathy

*

Key takeaways

* There are currently no approved treatments for symptomatic non-obstructive hypertrophic cardiomyopathy (HCM).

* The ACACIA-HCM trial compared the cardiac myosin i . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products